Harnessing Optimism and Perseverance in the Face of Long COVID-Español (NCT07216040)
Harnessing Optimism and Perseverance in the Face of Long COVID~Español (HOPE-LC~Español)
🩺 Plain-English Summary (8th-Grade Level)
The Harnessing Optimism and Perseverance in the Face of Long COVID (HOPE-LC) program, created by Drs. Eric Watson and Amelia Hicks, is a group therapy model designed to foster resilience, adjustment, and coping skills for those living with chronic Long COVID. HOPE-LC\~Español provides a culturally and linguistically adapted version for Spanish-speaking individuals in Queens, developed with input from Spanish-speaking clinicians, Long COVID experts, and people with lived experience. Partnering with H+H/Elmhurst and H+H/Queens, the project aims to recruit 25 participants and evaluate program feasibility and preliminary efficacy.
Who can join: Review the eligibility criteria below.
Location: Brain Injury Research Center — New York, New York
Age range: 18 Years
🧪 Interventions in This Study
- HOPE-LC~Espanol (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Brain Injury Research Center — New York, New York
📞 Contact the Study Coordinator
Phone: (212) 241-2221
Email: eric.watson@mountsinai.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Post-Acute COVID-19 Syndrome
- Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome — Nashville, Tennessee
- A Study of Positive Emotions With Long COVID-19 — Sacramento, California
- Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I) — Bethesda, Maryland
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research — Delafield, Wisconsin
- Dietary Intervention to Mitigate Post-Acute COVID-19 Syndrome — Baltimore, Maryland
Explore by condition: All Post-Acute COVID-19 Syndrome clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.